Le Lézard
Classified in: Health, Science and technology, Business
Subject: CON

Neogen partners with IGS to enhance Igenity® Beef Profile


LINCOLN, Neb., Sept. 19, 2019 /PRNewswire/ -- Neogen Corporation (Nasdaq: NEOG) today announced that it has entered into a collaboration with International Genetic Solutions (IGS). The effort is focused on heightening genomic impact in the IGS platform, the only major multibreed beef genetic evaluation available, and at the same time greatly enhancing the research and development necessary to continue to improve Neogen's Igenity® Beef Profile.

The Igenity Beef Profile is the leading global genetic testing product that helps producers of both purebred and crossbred beef cattle select their best animals for breeding programs. IGS delivers the most credible, objectively described, user-friendly and science-based genetic predictions to enhance the profitability of beef cattle producers who look to leverage the full power of expected progeny differences (EPDs).

"As part of this partnership, Neogen will benefit from access to information that will improve the Igenity Beef Profile, and IGS will endorse and promote the use of the product ? an important 'seal of approval' from one of the largest genetic evaluation services in the world," said Dr. Stewart Bauck, Neogen's vice president of agrigenomics. "As the beef industry continues to face pressure from competing sources of protein, the Igenity Beef Profile is a valuable tool to help our customers remain efficient and profitable. Selecting the best animals for breeding programs is now absolutely critical. Each replacement heifer represents an investment of about $2,000 per head in cost of development and lost sale opportunity."

The beef cattle sector is an important part of Neogen's agrigenomics business, and the Igenity Beef Profile is a significant driver of the growth of the company's business in North America and globally.

"This collaboration with IGS provides the research that will drive product improvement and development for a number of years, and will contribute to significant growth in revenue for this important cattle sector," said Bauck. "The Igenity Beef Profile was the first, and remains the only, globally available genomic selection tool proven to work in crossbred cattle."

The Igenity Beef Profile currently consists of genetically scoring animals on 16 maternal, performance and carcass traits, in addition to determining the animal's parentage. The profile is designed to help producers make confident decisions about heifers they retain and develop for their breeding herd. Some producers also use the profile in the production of high-value feeder calves and to score composite bulls.

Neogen recently enhanced its ability to serve the global animal genomics market by expanding its animal genomics laboratory services and bioinformatics to include locations in the United States, Scotland, Brazil, Canada, China and Australia. Neogen primarily serves the beef and dairy cattle, pig, sheep, poultry and companion animal markets with its genomics services.

For more information about IGS, visit: https://internationalgeneticsolutions.com/.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division is a leader in the development of animal genomics along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care and disinfectants.

CONTACTS: 

Tom Schultz, Neogen, [email protected]


Dr. Wade Shafer, CEO, American Simmental Association, [email protected]


Tom Brink, CEO, Red Angus Association, [email protected]

 

SOURCE Neogen Corporation


These press releases may also interest you

at 10:40
Florida Cancer Specialists & Research Institute, LLC (FCS) medical oncologist and hematologist Ernesto Bustinza-Linares, MD is co-author of a recent abstract published in the American Society of Clinical Oncology Journal, JCO Precision Oncology, that...

at 10:36
4WEB Medical, an orthopedic implant company focused on developing innovative implants that utilize its proprietary Truss Implant Technologytm, announced that it received regulatory clearance to market the newest addition to the company's anterior...

at 10:35
InfoMC Inc., a pioneer in medical management and behavioral health technology, and OptMyCare, a healthcare analytics company, today announced a partnership to integrate their technology solutions to optimize care orchestration and quality...

at 10:34
ReferralMD, a leader in healthcare technology solutions, is excited to announce the expansion of its Digital Front Door offering using the latest innovation in conversational AI. The Patient Registration & Intake Solution, powered...

at 10:34
Today, Orchard Software announced the availability of interface support for Antimicrobial Use and Resistance (AUR) reporting to the Centers for Disease Control and Prevention's (CDC) National Healthcare Safety Network (NHSN). Orchard's solutions send...

at 10:30
Biomarkers Market in terms of revenue was estimated to be worth $57.7 billion in 2024 and is poised to reach $93.8 billion by 2029, growing at a CAGR of 10.2% from 2024 to 2029 according to a new report by MarketsandMarketstm. The growing...



News published on and distributed by: